Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population
- PMID: 16083506
- PMCID: PMC1190195
- DOI: 10.1186/1471-2490-5-12
Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population
Abstract
Background: N-acetyltransferase 2 is phase II metabolizing enzyme that participates in the bioconversion of heterocyclic arylamines into electrophilic nitrenium ions, which are important ultimate carcinogens that are directly implicated in tumor initiation process. This study was conducted to examine; (1) whether the N-acetyltransferase 2 (NAT2) genotype is a risk factor for prostate cancer, (2) to study effect of NAT2 genotype on modifying prostate cancer risk from tobacco use.
Methods: The case control study was undertaken over a period of 28 months and included 130 prostate cancer patients (CaP) and 140 controls. The NAT2 genotypes were identified by PCR-RFLP method in DNA extracted from peripheral blood. Genotype frequencies and the association of genotypes with patients and control groups were assessed by logistic regression model.
Results: We observed non-significant association of rapid acetylator genotype NAT2 (OR = 1.452, 95% CI: 0.54-1.87, P = 0.136) in prostate cancer patients. However significant association was observed between rapid acetylator genotype NAT2 and CaP tobacco users (OR = 3.43, 95% CI: 1.68-7.02, P-value < 0.001) when compared with controls.
Conclusion: The data suggests that the NAT2 rapid acetylator genotypes may play an important role in determining the risk of developing prostate cancer particularly in the tobacco users of north Indian population.
Figures
Similar articles
-
Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in north Indian population.Cancer Invest. 2007 Aug;25(5):340-6. doi: 10.1080/07357900701358074. Cancer Invest. 2007. PMID: 17661210
-
Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population.Prostate. 2005 Aug 1;64(3):246-52. doi: 10.1002/pros.20241. Prostate. 2005. PMID: 15717312
-
[Relationship between genetic polymorphisms of metabolizing enzymes and prostate cancer].Zhonghua Nan Ke Xue. 2003 Feb;9(1):32-5. Zhonghua Nan Ke Xue. 2003. PMID: 12680328 Chinese.
-
Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):29-42. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10667461 Review.
-
N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction.Br J Cancer. 2000 Aug;83(3):412-7. doi: 10.1054/bjoc.2000.1265. Br J Cancer. 2000. PMID: 10917561 Free PMC article. Review.
Cited by
-
Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology.Front Public Health. 2022 Nov 17;10:1036722. doi: 10.3389/fpubh.2022.1036722. eCollection 2022. Front Public Health. 2022. PMID: 36466542 Free PMC article.
-
A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review.Med Oncol. 2011 Mar;28(1):365-76. doi: 10.1007/s12032-010-9423-5. Epub 2010 Jan 23. Med Oncol. 2011. PMID: 20099048 Review.
-
Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population.Environ Health Prev Med. 2013 Mar;18(2):136-42. doi: 10.1007/s12199-012-0302-x. Epub 2012 Sep 9. Environ Health Prev Med. 2013. PMID: 22961351 Free PMC article.
-
N-acetyltransferase-2 gene polymorphisms and prostate cancer susceptibility in Latin American patients.Med Oncol. 2012 Dec;29(4):2889-94. doi: 10.1007/s12032-012-0157-4. Epub 2012 Jan 14. Med Oncol. 2012. PMID: 22246524
-
Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus.Arthritis Res Ther. 2007;9(2):R23. doi: 10.1186/ar2134. Arthritis Res Ther. 2007. PMID: 17335581 Free PMC article.
References
-
- Hein DW, Doll MA, Gray K, Rustan TD, Ferguson RJ. Metabolic activation of N-hydroxy-2-acetylaminofluorene by NAT1 and NAT2 in colon cytosols of Syrian hamster congenic at the NAT2 locus. Cancer Res. 1993;53:509–514. - PubMed
-
- Vatsis KP, Weber WW, Bell DA. Nomenclature for N-acetyltransferase. Pharmacogenetics. 1995;5:1–17. - PubMed
-
- Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ, Grant DM. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis. 1993;14:1633–1638. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous